Skip to main content

Table 1 Summary of data collection process

From: Willingness to use HIV prevention methods among vaccine efficacy trial participants in Soweto, South Africa: discretion is important

a. Screening questionnaire

Data collected

Participant self-report on electronic computer tablet at recruitment

Name, phone numbers, age range, gender, sexual orientation, HIV status, length of participation in HVTN 702 study, HVTN study number

Interviewer-administered by telephone calls with potentially eligible participants

Willingness to participate in FGD, availability considerations for scheduling FGD

b. Demographic questionnaire

Variables assessed

Participant self-report with pen and paper format questionnaire immediately prior to FGD

Date of birth, gender, sexual orientation, marital status, highest level of education completed, average monthly household income, source of income in the last three months, housing type, HIV risk perception of self and of partner

c. Focus group discussion

Topics

Semi-structured interview guide

Overall HIV prevention knowledge, experience and perceptions about HIV vaccines, HIV counselling and testing, condoms, VMMC, antiretroviral medications, PrEP, hypothetical methods and ultimate preferences for prevention